BoneMRI
Radiation-free bone and soft tissue imaging method generating 3D CT-like images from MRI scans
Company profile
Company profile
MRIguidance B.V. is a medical imaging technology company that has developed BoneMRI, an innovative software solution that generates 3D CT-like images to visualize bone structures derived from MRI scans. The company's flagship product enables radiation-free bone and soft tissue imaging, addressing a critical need in spine surgery planning, musculoskeletal diagnostics, and surgical navigation. BoneMRI creates synthetic CT images from standard MRI scans, providing clinicians with detailed bone visualization without exposing patients or medical staff to harmful ionizing radiation. The technology seamlessly integrates into existing clinical workflows, automatically reconstructing images and forwarding them to PACS systems while maintaining compatibility with all major MRI scanners. MRIguidance serves healthcare providers including hospitals, surgical centers, and radiology departments, with particular applications in spine surgery, orthopedics, and rheumatology. The company's solution addresses multiple anatomical areas including cervical, thoracic, and lumbar spine, as well as the pelvic region. By eliminating the need for CT scans in many clinical scenarios, BoneMRI streamlines workflows, reduces costs, improves patient safety, and enables more efficient surgical planning and navigation. The technology has been validated through extensive clinical research published in leading medical journals and is being adopted by major medical centers globally.
Company description MRIguidance B.V official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Hybrid · Other deployment with recorded integration context.
Recorded integration context: Major MRI scanner platforms, PACS systems.
Company milestones
Leadership transition with Guido Zijl appointed CEO (Feb 2026); BoneMRI trademark registration secured in US, UK, and EU (Oct 2025); New release with stitching functionality and expanded scanner support (Feb 2026); First human spine surgery based on BoneMRI performed at Robotic Spine Institute of Las Vegas
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Radiation-free bone and soft tissue imaging method generating 3D CT-like images from MRI scans
Radiation-free 3D bone imaging specifically designed for young patients
Enhanced T1-weighted contrast imaging from single MRI source
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Physics in medicine and biology · Apr 24, 2026
The safety and accuracy of radiation-free spinal navigation using a short, scoliosis-specific BoneMRI-protocol, compared to CT.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · Jan 1, 2026
Deep Learning Based Automatic Ankle Tenosynovitis Quantification from MRI in Patients with Psoriatic Arthritis: A Feasibility Study.Diagnostics (Basel, Switzerland) · Jun 9, 2025
A multipurpose, adolescent idiopathic scoliosis-specific, short MRI protocol: A feasibility study in volunteers.European journal of radiology · Aug 1, 2024
Magnetic resonance imaging-based bone imaging of the lower limb: Strategies for generating high-resolution synthetic computed tomography.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · Apr 1, 2024
MRI-based synthetic CT in the detection of knee osteoarthritis: Comparison with CT.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · Nov 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
K233030 · 510k · Mar 1, 2024
BoneMRI v1.6K230197 · 510k · Feb 22, 2023
BoneMRIK202404 · 510k · Dec 22, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Eliminates ionizing radiation for patients and staff compared to CT imaging
Single MRI exam provides all necessary information, eliminating need for separate CT scans
Automatic reconstruction and PACS integration streamlines clinical workflow
Multiple studies demonstrate equivalence to conventional CT for surgical planning and diagnosis
First human spine surgery based on BoneMRI for surgical planning and navigation
Successfully completed first human spine surgery using BoneMRI for radiation-free surgical planning
Radiation-free 3D bone imaging for adolescent patients requiring spine surgery
Young patients spared significant radiation dose while surgeon obtains accurate 3D information
Clinical implementation of BoneMRI for spine imaging and surgical planning
Successful clinical adoption of radiation-free bone imaging technology
05 · Leadership
Leadership profiles and professional links from the current Company record.
Guido Zijl
CEO
Roel Kellenaers
Former CEO
06 · Company updates
Recent articles published on MRIguidance B.V's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.